Medicare overhaul restricts vitamin D and B12 tests

The MBS items for vitamins D and B12 testing have been overhauled to confine their use to high-risk patients in a bid to prevent "screening".

MBS items 66608 and 66609 for vitamin D testing were abolished on 1 November and replaced with new items that have specific clinical criteria.

The new 66833 item covers 25-hydroxyvitamin D testing for high-risk groups, such as people who have "deeply pigmented skin, or